Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2003
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003CA2462913A1 Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
04/17/2003CA2462892A1 Human 3 relaxin
04/17/2003CA2462886A1 Flashmelt oral dosage formulation
04/17/2003CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003CA2462806A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
04/17/2003CA2462801A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2461435A1 Angiopoietin-2 specific binding agents
04/17/2003CA2461064A1 Inhibition of stat-1
04/17/2003CA2460625A1 Structural and cytoskeleton-associated proteins
04/17/2003CA2460476A1 Protein modification and maintenance molecules
04/17/2003CA2458473A1 Pharmaceutical formulation
04/17/2003CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003CA2426384A1 Antibody inhibiting vplf activity
04/16/2003EP1302542A1 Novel physiologically active peptide and use thereof
04/16/2003EP1302536A2 Embryonic stem cells and neural progenitor cells derived therefrom
04/16/2003EP1302470A1 Lipid-rich plaque inhibitors
04/16/2003EP1302462A1 Sulfone derivatives, process for their production and use thereof
04/16/2003EP1302207A2 Method for preparing an antihypertensive agent containing a dipeptide as active ingredient
04/16/2003EP1302206A1 Methods and means for the use of the adventitial toll-like receptor
04/16/2003EP1302201A1 Pharmaceutical composition improved in peroral absorbability
04/16/2003EP1302104A1 P300 transgenic animal
04/16/2003EP1301598A2 Cell cycle proteins and mitosis-associated molecules
04/16/2003EP1301597A2 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
04/16/2003EP1301595A2 G-protein coupled receptors
04/16/2003EP1301593A2 ANTISENSE COMPOSITIONS TARGETED TO $g(b) 1? ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE
04/16/2003EP1301535A2 G-protein coupled receptors
04/16/2003EP1301534A2 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis
04/16/2003EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies
04/16/2003EP1301517A1 Thienopyrrolidinones
04/16/2003EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
04/16/2003EP1301510A1 New bispidine compounds and their use in the treatment of cardiac arrhythmias
04/16/2003EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
04/16/2003EP1301506A1 Cyclic amino acid derivatives
04/16/2003EP1301504A1 Bifunctional agents possessing antioxidant and antiarrhythmic activity
04/16/2003EP1301502A1 Novel compounds and their use as glycine transport inhibitors
04/16/2003EP1301501A1 Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect
04/16/2003EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
04/16/2003EP1301497A1 Colchinol derivatives as vascular damaging agents
04/16/2003EP1301495A2 Inhibitors of copper-containing amine oxidases
04/16/2003EP1301490A2 5-substituted 2-aryl-4-pyrimidinones
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP1301211A2 Multifunctional nanodevice platform
04/16/2003EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
04/16/2003EP1301201A1 Treatment of glycogen storage disease type ii
04/16/2003EP1301200A2 Peptide pharmaceutical formulations
04/16/2003EP1301181A2 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
04/16/2003EP1301173A1 A medicinal aerosol formulation
04/16/2003EP1301076A2 Enhancing therapeutic effectiveness of nitric oxide inhalation
04/16/2003EP1218022B1 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
04/16/2003EP1181017B1 Metalloprotease inhibitors
04/16/2003EP1102769B1 Tricyclic carboxamides
04/16/2003EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
04/16/2003EP1056449B1 20-hete antagonists and agonists
04/16/2003EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential
04/16/2003EP0942896B1 Substituted phenols and thiophenols useful as antioxidant agents
04/16/2003EP0873404B1 Angiotensin converting enzyme inhibitors
04/16/2003EP0869945B1 Catechol diethers derivatives useful as pharmaceutical agents
04/16/2003EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
04/16/2003EP0642356B1 Antibodies to p-selectin and their uses
04/16/2003EP0591462B1 Universal donor cells
04/16/2003CN1411556A Synergistic activation of regulatory elements by Rel proteins and steroid receptor
04/16/2003CN1411466A Compound (I), method for extracting it and pharmaceutical composition containing it
04/16/2003CN1411458A Saccharin derivatives as orally active elastase inhibitors
04/16/2003CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
04/16/2003CN1411447A Polymorphic crystalline forms of celecoxib
04/16/2003CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
04/16/2003CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
04/16/2003CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
04/16/2003CN1411388A Methods for extraction and reaction using supercritical fluids
04/16/2003CN1411379A Preventives or remedies for arrhythmia
04/16/2003CN1411376A Novel helicobacter pylori-binding substances and use thereof
04/16/2003CN1411374A Substituted piperazine and piperidine calcium channel blockers
04/16/2003CN1410121A Medicine for treating archosyrinx and its preparation method
04/16/2003CN1410090A Liuhexinpi oil preparation, its formulation and preparation technology
04/16/2003CN1410088A Medicine for treating apoplexia hemiplegia
04/16/2003CN1410068A Preparation method of water soluble tanshinone
04/16/2003CN1410063A Embedding agent for long acting blood pressure reducing
04/16/2003CN1410061A Nimudipin undertongue spraying agent
04/16/2003CN1409999A Method for extracting black-bone chicken extract (natural juice) and black-bone chicken extract obtained thereby
04/16/2003CN1105723C Spirocyclic metalloprotease inhibitors
04/16/2003CN1105711C 嘧啶衍生物 Pyrimidine derivatives
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/16/2003CN1105705C Process for preparing heterocyclic amide derivative with specific physical status
04/16/2003CN1105576C Insulin analog formulation
04/16/2003CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products
04/16/2003CN1105573C Pharmaceutical composition
04/16/2003CN1105569C Medicinal composition for stasis of blood
04/15/2003US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders
04/15/2003US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives
04/15/2003US6548693 Nitriloxy derivatives of (R) and (S)-carnitine
1 ... 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 ... 1595